Published on March 3, 2014
Tom Hedman, PhD Founder
Snoring: 48% of men, 34% of women & growing (obesity, allergies, aging) Sleep deprivation – snorer; sleep cycle disruption, stress – family Can lead to OSA Obstructive Sleep Apnea: Breathing interrupted during sleep by obstruction of the airway US: 4.2% age 16 & older, ~10 million adults & growing Over age 65: 28% of men, 24% of women
NEXT NEXT - Nonsurgical EXogenous Crosslink Therapy • • • • Injectable Collagen Crosslinking Immediate effect Permanent covalent bonds Low cost – high profit margin genipin
Equine Soft Palate Collagen Content (hyp, nmol/mg) Achilles Tendon Skin Annulus Fibrosus Aorta Soft Palate Spleen Kidney Liver 0.0 Collagen Mapping 200.0 400.0 600.0 800.0 1000.0
Wind Tunnel Video: Experiments with untreated (brown) and treated (dark blue) equine soft palates
Transient Comparison Time(sec) vs Displacement (cm) 0.45 0.4 Displacement (cm) 0.35 0.3 69% Reduction in Maximum Transient Deformation 0.25 0.2 Control Treated 0.15 0.1 0.05 0 0 1 2 3 Time (seconds) 4 5 6
51% Reduction in Steady State Vibration Amplitude 0.05 0.04 Virtual Elimination of Low Frequency – High Energy Vibration Treated 0.03 Displacement (cm) Control 0.02 0.01 0 -0.01 0 0.1 0.2 0.3 0.4 0.5 -0.02 -0.03 -0.04 Time (seconds) 0.6 0.7 0.8 0.9 1
Competitive Advantage: Primary competition: Existing surgical treatments Oral appliances that alter geometry of pharynx/ upper airway (incl. CPAP) Minimally invasive “stiffening” procedures Competition: inconsistent, limited or temporary effectiveness; invasive (surgery), inconvenient or uncomfortable (oral appliances, CPAP); Existing and emerging minimally invasive procedures rely on formation of scar tissue – which is inherently disorganized, weak, easily degraded NEXT – Effective! Preserves matrix integrity, strengthens tissue
Patent Portfolio • 10 US and 7 international patents issued or in condition for allowance • Snoring – Obstructive Sleep Apnea specific patent pending • Additional 20+ US and international patents pending Issued Patents US Foreign 10/230,671 Found in condition for allowance Australia 2002335683 7,435,722 Canada 2,458,821 8,153,600 Australia 2004268628 8,022,101 Japan 2006-524909 8,119,599 Canada 2,536,415 8,198,248 Korea 8,211,938 Australia 2010266306 Claims found allowable 8,283,322 8,450,276 12/966,812 Found in condition for allowance
Management Team Lyle T. Hawkins CEO/President Tom Hedman, PhD Founder, CSO Elsa Abruzzo VP Reg./Clinical Affairs Ind.& Manuf. Engineering • Over 10 years experience with new business development; successful in funding and market launch of a host of consumer, commercial, and medical/chemical products • Formerly VP-Product Management & Marketing for Landmark Earth Solutions (newly formed and wholly owned subsidiary of Leggett & Platt); held senior positions with Robert Bosch, The Coleman Company, Vermont American, and Char-Broil • MBA - Bellarmine University, BS - Florida State Univ., adjunct faculty - Indiana Wesleyan Univ. • Founder of 7 biotech companies, 25+ years in biomechanics research, led 1st North American artificial disc design/ development team • Graduate of MIT, & Ph.D. in Bioengineering from Strathclyde University • Currently Associate Professor at University of Kentucky • 20+ years in medical device regulatory , clinical, and quality functions • Successful in bringing a crosslinking technology through FDA as Class III Med. Dev. • Worked at Baxter, Cordis J&J, CryoLife (Dir), Percutaneous Valve Technologies (Sr. Dir. – Head RA/CA), and AtriCure (VP) with successful FDA approval track record • Maintains her RAPS Regulatory Affairs Certification
Funding required for 2014-2015: $250k ($1.25M initial valuation) Patent prosecution and annuity costs Gap funding R&D – between NIH SBIR Phase I and Phase II grants Partial support for CEO/President – business plan development, market research Contact Tom Hedman for more information: firstname.lastname@example.org
Calcification Inhibitors in CKD and Dialysis Patients
They team up people from across the org chart and link rewards to innovation. Innovative companies build ... technology services company that ...
Introduction to innovation Definitions ... useful technologies coupled with a need to exceed the competition in these technologies What is innovation?
... companies require not only the technology, ... distinguish the most successful companies from the rest. ... innovation benefits from a diversity of ...
Isis Innovation Ltd is the University of Oxford’s wholly owned technology transfer company. ... Introduction to Isis. Isis Innovation Ltd is the ...
The Innovation Company; Distributors; Intra. TIC Intranet; ... Cosmetics Innovations and Technologies Sarl. email@example.com +33 (0)2 37 42 18 34.
Technology and Innovation ... from Innovation—Introduction to Our ... Corporations & Venture Companies on Technology Development for ...
The world of work is changing with the increase in the use of technology and both companies and ... (person or company) develops an innovation ...
Odebrecht Entrepreneurial Technology. Introduction; ... Technology and Innovation. ... with the rest of the continent, ...
Knowledge Management and Innovation in Service Companies ... INTRODUCTION ... tourism company and a technology company and has enhanced its resources for
Innovations in Food Packaging addresses ... to Active Food Packaging Technologies Introduction Drivers for Choice of Active ... Company Information; Press ...